白宫官员：如果药品行业未取得充分进展，卫生部长将通过制定规则实施最惠国定价。

Core Viewpoint - The White House officials indicated that if the pharmaceutical industry does not make sufficient progress, the Secretary of Health will implement rules for Most Favored Nation pricing [1] Group 1 - The Secretary of Health is prepared to take action if the pharmaceutical industry fails to meet expectations [1] - The Most Favored Nation pricing strategy aims to ensure that drug prices are aligned with the lowest prices paid by other countries [1] - This potential regulatory move reflects ongoing concerns about high drug prices in the U.S. and the need for reform in the pharmaceutical sector [1]